Clonal evolution of preleukemic hematopoietic stem cells in acute myeloid leukemia

Experimental Hematology

Volumn 43, Issue 12, 2015, Pages 989-992

  Sykes, Stephen M ^a   Kokkaliaris, Konstantinos D ^b   Milsom, Michael D ^c   Levine, Ross L ^d   Majeti, Ravindra ^e  

^a FOX CHASE CANCER CENTER   (United States)

^b ETH ZURICH   (Switzerland)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; CD135 ANTIGEN; COHESIN; ISOCITRATE DEHYDROGENASE 1; ISOCITRATE DEHYDROGENASE 2;

ACUTE MYELOBLASTIC LEUKEMIA; BIOACCUMULATION; CELL SELF-RENEWAL; CLONAL EVOLUTION; CYTOGENETICS; DNA METHYLATION; DRUG EFFICACY; EPIGENETICS; GENE DELETION; GENE EXPRESSION; GENE SEQUENCE; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMIA REMISSION; LEUKEMOGENESIS; MALIGNANT TRANSFORMATION; NONHUMAN; PRELEUKEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; METABOLISM; PATHOLOGY; PRECANCER;

ANIMALS; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; PRECANCEROUS CONDITIONS;

EID: 84961391278     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2015.08.012     Document Type: Review

References (13)

1. Walter M.J., Payton J.E., Ries R.E., et al. Acquired copy number alterations in adult acute myeloid leukemia genomes. Proc Natl Acad Sci U S A 2009, 106:12950-12955.
2. Ley T.J., Ding L., Walter M.J., et al. DNMT3A mutations in acute myeloid leukemia. N Engl J Med 2010, 363:2424-2433.
3. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 2013, 368:2059-2074. Cancer Genome Atlas Research Network.
4. Jan M., Snyder T.M., Corces-Zimmerman M.R., et al. Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia. Sci Transl Med 2012, 4:149ra118.
5. Corces-Zimmerman M.R., Hong W.J., Weissman I.L., Medeiros B.C., Majeti R. Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission. Proc Natl Acad Sci U S A 2014, 111:2548-2553.
6. Moran-Crusio K., Reavie L., Shih A., et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell 2011, 20:11-24.
7. Quivoron C., Couronne L., Della Valle V., et al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 2011, 20:25-38.
8. Challen G.A., Sun D., Jeong M., et al. Dnmt3a is essential for hematopoietic stem cell differentiation. Nat Genet 2012, 44:23-31.
9. Challen G.A., Sun D., Mayle A., et al. Dnmt3a and Dnmt3b have overlapping and distinct functions in hematopoietic stem cells. Cell Stem Cell 2014, 15:350-364.
10. Sasaki M., Knobbe C.B., Munger J.C., et al. IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics. Nature 2012, 488:656-659.
11. Shih A.H., Jiang Y., Meydan C., et al. Mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemia. Cancer Cell 2015, 27:502-515.
12. Cai X., Gao L., Teng L., et al. Runx1 deficiency decreases ribosome biogenesis and confers stress resistance to hematopoietic stem and progenitor cells. Cell Stem Cell 2015, 17:165-177.
13. Chan S.M., Thomas D., Corces-Zimmerman M.R., et al. Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia. Nat Med 2015, 21:178-184.